Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1289776

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1289776

Global Next Generation Contact Lenses and Visual Prostheses Market - 2023-2030

PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Market Overview

The Global Next Generation Contact Lenses And Visual Prostheses Market reached US$ 172.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 608.0 million by 2030. The global next generation contact lenses and visual prostheses market is expected to exhibit a CAGR of 17.7% during the forecast period (2023-2030).

Next-generation contact lenses are more advanced than traditional contact lenses and can correct a wider range of vision problems. next-generation contact lenses and visual prostheses are devices that replace the function of the eye's natural lens after it has been removed or damaged. They can be used to treat cataracts, glaucoma, and other eye conditions.

The rising prevalence of retinal diseases amongst the geriatric population is one of the major drivers for the next generation contact lenses & visual prostheses market. The most prevalent retinal diseases are AMD, hypertensive retinopathy, epiretinal membrane, BRVO, and diabetic retinopathy.

Market Dynamics

Rising Prevalence of Eye Related Diseases

The frequency of eye diseases is increasing globally, particularly in India. For instance, according to the World Health Organization (WHO), at least 2.2 billion people worldwide suffer from near- or far-sightedness. According to the World Health Organization, if the patient had received the proper diagnosis and care, at least one billion cases of vision impairment may have been avoided.

Due to a hectic lifestyle, cases of vision loss are on the rise in India. According to a large-scale study, which included data from 14.5 lakh patients, the number of cases of dry eye disease increased to 21,000 in 2019. It states that India is on the verge of a dry eye disease epidemic. By 2030, it will affect approximately 40% of the urban population.

Shortage of Ophthalmologists

Although the need for ophthalmologists has expanded dramatically in recent years. This is especially noticeable in underdeveloped nations. In India, for example, there is one ophthalmologist for every 90,000 people, but the US has a ratio of 1:15. The average number of ophthalmologists per million people varies according to economic development, ranging from 9 per million in low-income nations to 79 million in high-income countries.

COVID-19 Impact Analysis

The pandemic has hampered the advancement of next-generation contact lens research and development. Lockdowns, social distancing tactics, and restricted financing prospects have caused disruptions in laboratories and research facilities. This might possibly push back the timescale for bringing new innovations to market.

The pandemic has had a substantial impact on the global supply chain, causing interruptions in the manufacture and delivery of many items. These disruptions have the potential to influence the manufacture and availability of next-generation contact lenses, including the procurement of materials, components, and manufacturing equipment.

Segment Analysis

The global next generation contact lenses and visual prostheses market is segmented based on type of product , type of diseases and end user .

The Contact Lens Segment will be Dominated by Market Players During the Forecast Period

Contact lens is expected to be the dominating segment with the percentage around 81.3% in the forecast period as a result of product launches and approvals. For instance, Alcon Canada, for example, introduced new total toric lenses for astigmatic patients. Alcon, a worldwide pioneer in eye care devoted to helping people see brilliantly, announced the Canadian debut of a total of 30 for Astigmatism and Dailies Total 1 Astigmatism.

Alcon's line of reusable and daily disposable lenses has been expanded with high-performing solutions targeted at astigmatic patients. According to estimates, toric lenses (for astigmatic correction) are the fastest expanding section of the contact lens industry, providing an opportunity for eye care specialists to deliver excellent vision correction and patient care.

Geographical Analysis

North America is the Dominating Region During the Forecast Period

North America dominates the market for next-generation contact lenses and visual prostheses accounting for 42.1% and this trend is expected to continue during the projected period. The region's dominance is likely to continue during the projection period, owing to factors such as rising diabetes incidence, high disposable income, and growing awareness of modern technology for the treatment of eyesight impairment.

Due to factors such as improved healthcare infrastructure and the availability of innovative medicines for treating blindness, as well as economic expansion in countries such as India and China, the Asia Pacific area is expected to be the fastest-growing regional sector throughout the projection period.

Competitive Landscape

The major global players include: Johnson & Johnson, NIDEK, Novartis, Second Sight, NJ Retina, Interojo, OcuMedic, Bausch & Lomb, Pixium Vision, Menicon, and others.

  • Why Purchase the Report?
  • To visualize the global next generation contact lenses and visual prostheses market segmentation based on the type of product, type of diseases, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global next generation contact lenses and visual prostheses market level with all segments.
  • Pdf report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global next generation contact lenses and visual prostheses market report would provide approximately 92 tables, 108 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: MD1440

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by type of product
  • 3.2. Snippet by type of diseases

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising prevalence of retinal diseases amongst the geriatric population
    • 4.1.2. Restraints
      • 4.1.2.1. Shortage of Expert ophthalmologists
    • 4.1.3. Opportunity
      • 4.1.3.1. Increasing product launches and approvals
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Type of Product

  • 7.1 Contact lens
  • 7.2 Visual Prostheses

8. By Type of Diseases

  • 8.1. Glaucoma
  • 8.2. Diabetes
  • 8.3. AMD
  • 8.4. Retinitis Pigmentosa
  • 8.5. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. The U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. The UK
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Johnson & Johnson
  • 11.2. NIDEK
  • 11.3. Novartis
  • 11.4. Second Sight
  • 11.5. Menicon
  • 11.6. NJ Retina
  • 11.7. Interojo
  • 11.8. Pixium Vision
  • 11.9. OcuMedic
  • 11.10. Bausch & Lomb

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!